Explore our Resources
Access a curated collection of materials designed to provide insights into our capabilities and expertise across the drug development and manufacturing lifecycle.
Resources
Whaitepaper
Driving the Shift to Subcutaneous Biologics
The subcutaneous shift has already happened. Is your pipeline ready? In 2000–2004, 25% of FDA biologic approvals were device-based. By 2023-2025, 74% were. OneSource delivers the complete subcutaneous (SC) development stack –…
On-Demand Webinar
Accelerating GLP-1 Peptides to Market Through Integrated Formulation & Analytical Development
GLP-1 peptide therapeutics are rapidly reshaping the treatment landscape for diabetes and obesity, increasing the need for robust formulation development and comprehensive analytical characterization strategies that enable safe, scalable, and market-ready drug…
Scientific articles
Supply chain resilience is not an insurance cost, but value protection
Supply chain resilience is not an insurance cost, but value protection Anurag Bhagania, Chief Financial Officer Published on BW CFO World, 14 Apr2026 For a long time, the ‘ideal’ supply chain was…
Scientific articles
CDMOs as innovation partners in R&D
CDMOs as innovation partners in R&D Prateek Gupta, SVP & head, Technical Development Published on Hindustan Times, 22 Mar 2026 Pharma research and development (R&D) is moving faster and getting harder at…